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Long non-coding RNAs are attracting
the attention of researchers in many
fields. These RNAs are longer than 200
nucleotides and do not encode any pro-
tein. A subset of them is reported to be
strongly correlated with poor patient prog-
nosis, suggesting a potential role in cancer
progression (Esteller, 2011).
Gastric cancer is one of the most
common malignant tumors worldwide.
Therefore, there is an urgent need to find
genes which are helpful in the diagno-
sis, prognosis, and understanding of the
molecular pathways of this cancer (Hajjari
et al., 2013a).
Finding novel molecular biomarkers of
malignancy has been always important
for clinical management. Like proteins,
mRNAs, and miRNAs, lncRNAs show
potentials as novel biomarkers and ther-
apeutic targets in different cancer types
(Zhang et al., 2013). However, there are a
few reports on studying the relationship
between gastric cancer progression and
lncRNAs. Some useful clues for further
researches seem necessary for deciphering
the potential role of lncRNAs in gastric
cancer. In this report, we present and high-
light some evidences about the potential
role of lncRNAs in gastric cancer based on
the data indicated inMicroarray databases.
The results may give novel perspectives for
further researches on the role of lncRNAs
in gastric carcinogenesis.
We used different databases including
Oncomine, Gene Expression Atlas, Gene
Expression Omnibus (GEO), and Array
Express Databases to analyze the expres-
sion level of most recent cited and noted
lncRNAs in studies on cancer progres-
sion (Niland et al., 2012; Zhang et al.,
2013). The selected lncRNAs have been
regarded as the most potential biomark-
ers in the studies on different cancer
types (Zhang et al., 2013). The RNAs
include H19, MALAT-1, HOTAIR, ANRIL,
CRNDE, and MEG3. Some descrip-
tions of these lncRNAs are presented
below.
Oncomine cancer microarray database
was used to mine the lncRNA expression
profile data according to the estab-
lished methodology (Rhodes et al.,
2007). Four publicly available datasets
[Chen Gastric (Chen et al., 2003),
DErrico Gastric (D’Errico et al., 2009),
Wang Gastric (Wang et al., 2012), and Cho
Gastric (Cho et al., 2011)] were inquired
for our analysis. By using Oncomine and
other microarray expression data acces-
sible from GEO, Gene expression Atlas,
and Array Express database, we found
some significant differences of expression
level for the lncRNAs. The datasets and
clinopathological data of each study are
presented in Table 1.
Student’s t-test was used for the dif-
ferential expression analyses. Those which
have significant differences (Fold change>
1.5, P-value< 0.01) between gastric cancer
and normal tissues are brought in Table 2.
MALAT-1
We found that the expression level of
MALAT-1 is not significantly different
between gastric cancer and normal tis-
sues in the datasets. MALAT-1 was orig-
inally identified to be up-regulated in
patients at the high risk of metastasis
of non-small cell lung tumors (NSCLC).
It seems that MALAT-1 functions in the
regulation of alternate splicing by modu-
lating the activity of SR proteins (Ji et al.,
2003).
ANRIL
There are some reports indicating that
ANRIL plays an important role in the
repression of P14ARF, P15INK4b, and
P16INK4a. The proposed mechanism of
ANRIL is an interaction with Polycomb
complexes and silencing target genes.
Although some relationships between
the ANRIL gene and cancer progression
have been reported (Yu et al., 2008), we
could not find any significant differences
of expression between gastric tumor and
normal tissues in the datasets.
CRNDE
CRNDE has been identified as an lncRNA
whose expression is highly elevated in
some tumors. It seems that CRNDE is
associated with a “stemness” signature in
some cancer types (Ellis et al., 2012).
For the expression of this lncRNA, we
did not find any significant differences
between gastric cancer and normal tissues
in selected datasets.
HOTAIR
The datasets show that this lncRNA is up-
regulated in gastric adenocarcinoma com-
pared with normal tissues. HOTAIR is an
lncRNA that binds to the PRC2 complex
and targets it at some genes involved in
tumor suppression. Its up-regulation is
reported in different cancer types (Gupta
et al., 2010).
H19
There is a significant up-regulation in
gastric adenocarcinoma tissues compared
with normal ones in our results drawn
from databases (Table 2). H19 is an
lncRNA which is implicated as having
both oncogenic and tumor suppression
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Table 1 | Different datasets and their clinicopathological data used in the current study.
Dataset Clinicopathological data (number of cases) References
ONCOMINE DATABASE
Chen gastric Normal tissues (29)
Diffuse gastric adenocarcinoma (13)
Gastric adenocarcinoma (15)
Gastric intestinal type adenocarcinoma (67)
Gastric mixed adenocarcinoma (8)
Chen et al., 2003
DErrico gastric Normal tissues (31)
Diffuse gastric adenocarcinoma (6)
Gastric adenocarcinoma (2)
Gastric intestinal type adenocarcinoma (26)
Gastric mixed adenocarcinoma (4)
D’Errico et al., 2009
Wang gastric Normal tissues(15)
Gastric cancer (12)
Wang et al., 2012
Cho gastric Normal tissues(19)
Gastric adenocarcinoma (65)
Gastrointestinal stromal tumor (6)
Cho et al., 2011
GENE ATLAS DATABASE
Normal tissues (31)
Gastric tumors (38)
D’Errico et al., 2009
ARRAY EXPRESS DATABASE
E-MTAB–1440 Normal mucosa(20)
Gastric adenocarcinoma(20)
Released in Database
GEO DATABASE
GSE22804 Marginal non-malignant tissue (14)
Gastric adenocarcinoma (14)
Marimuthu et al., 2011
GSE27342 Normal tissues (80)
Gastric cancer (80)
Cui et al., 2011
Table 2 | Significant difference (Fold change > 1.5, P-value < 0.01) of the expression level of lncRNAs between gastric cancer types and normal
tissues.
lncRNA Fold change/
T statistics
P-value Category1 (down
regulated)
Category2 (up-regulated)
ONCOMINE DATABASE
HOTAIR 4.419
4.905
3.06E–4
1.99E–5
Normal
Normal
Diffuse gastric adenocarcinoma
Gastric intestinal type adenocarcinoma
H19 4.396
2.084
3.117
2.21E–11
0.003
1.16E–6
Normal
Normal
Normal
Gastric adenocarcinoma
Diffuse gastric adenocarcinoma
Gastric intestinal type adenocarcinoma
MEG3 1.572 0.003 Gastric mixed
adenocarcinoma
Normal
GENE ATLAS DATABASE
HOTAIR 3.2 0.008 Normal Gastric cancer
H19 5.6 5.23E–6 Normal Gastric cancer
GEO AND ARRAY EXPRESS DATABASE
H19 1.5
3.84
6.9
2.17E–4
0.0001
0.0001
Normal
Normal mucosa
Marginal non-malignant
tissue
Gastric cancer
Gastric adenocarcinoma
Gastric adenocarcinoma
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properties. These two controversial roles of
H19may be attributed to the nature ofH19
function or context in different tissues.
Our results may support its oncogenic role
in gastric carcinogenesis.
MEG3
MEG3 is an lncRNA which is identified as
having an inhibitory role in tumor growth.
This lncRNA is the first one proposed
to have a tumor suppressor role (Zhang
et al., 2003). By querying the databases, we
found that the expression level of MEG3
is down-regulated in gastric adenocarci-
noma compared with normal tissues.
Altogether, based on the results,
it seems that some lncRNAs such as
HOTAIR, H19, and MEG3 may potentially
be suitable candidates for study in order
to find some biomarkers or therapeutic
targets. Hajjari et al. found a signifi-
cant up-regulation of HOTAIR lncRNA
in gastric adenocarcinoma tissues com-
pared with normal ones by Real-time
PCR (Hajjari et al., 2013b). Also, Yang
et al. found that H19 levels were increased
in gastric cancer cells and tissues com-
pared with normal controls (Yang et al.,
2012). These studies provide supportive
evidences concerning the important role
of these two lncRNAs in gastric cancer
progression.
The different expression of certain
cancer type-specific lncRNAs can be
exploited for the development of novel
biomarkers as lncRNA expression (Gibb
et al., 2011). Although there are some
reports indicating the effect of down-
regulation of HOTAIR and H19 on cell
proliferation and metastasis (Yang et al.,
2012; Xu et al., 2013), we believe that
these functional studies are worth being
undertaken on more samples. Besides,
understanding their biological roles in
normal developments might provide
some directions for using these enig-
matic molecules as diagnostic or predictive
biomarkers.
Our results, drawn from microarray
databases, may help researchers to inves-
tigate the role of lncRNAs in gastric can-
cer progression. Large scale and follow-up
studies are necessary to consider lncRNAs
such as HOTAIR and H19 as potential
biomarkers or therapeutic targets in this
type of cancer.
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